ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79% strict CR at abstract submission cut-off Positive updated data from iadademstat in relapsed/refractory FLT3-mut AML also accepted at …